InsidersTradesSigma
Genmab A/S: directors' dealings · Denmark · Finanstilsynet DK
DK:genmab-asDK0010272202DK·Finanstilsynet DKMcap 124.9Bn€
Explore the full management transaction log of Genmab A/S, a listed equity based in Denmark. Shares are listed on DK DK, under the authority of Finanstilsynet DK. Market capitalisation: €124.9bn. The latest transaction was disclosed on 1 April 2026 — Other. Among the most active insiders: Unknown. Every trade is accessible without an account.
140
Insider Decl.
0
Thresholds
€9m
16 ops.
Buy Volume
€33m
25 ops.
Sell Volume
Financial data
Income statement
Revenue3.72 Bn€
Gross profit3.48 Bn€94% margin
Net income963.0 M€25.9% margin
Balance sheet & cash
Market cap124.86 Bn€
Total debt5.43 Bn€
Free Cash Flow1.13 Bn€
Last declaration on 1 April 2026
Declarations0 total
No declarations found
0 of 0 declarations
About Genmab A/S
Genmab A/S is a Danish biopharmaceutical company focused on developing therapeutic antibodies for cancer treatment. It is listed on the Copenhagen Stock Exchange.
